VHPKQHR peptide modified magnetic mesoporous nanoparticles for MRI detection of atherosclerosis lesions
Mortality attributable to atherosclerosis can be reduced significantly with timely diagnosis and treatment. It is meaningful to find a proper way to diagnose and prevent the progression of atherosclerosis. Vascular cell adhesion molecule-1 (VCAM-1) expressed by endothelial cells is a prominent marke...
Main Authors: | Wan Xu, Shuihua Zhang, Quan Zhou, Wenli Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-12-01
|
Series: | Artificial Cells, Nanomedicine, and Biotechnology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21691401.2019.1626411 |
Similar Items
-
Hyaluronic Acid-Functionalized Mesoporous Silica Nanoparticles Loading Simvastatin for Targeted Therapy of Atherosclerosis
by: Kechen Song, et al.
Published: (2022-06-01) -
Functionalized Periodic Mesoporous Silica Nanoparticles for Inhibiting the Progression of Atherosclerosis by Targeting Low-Density Lipoprotein Cholesterol
by: Hao Jin, et al.
Published: (2024-01-01) -
In vitro Targetability Validation of Peptide-Functionalized Mesoporous Silica Nanoparticles in the Presence of Serum Proteins
by: Valeriy M. Paramonov, et al.
Published: (2020-11-01) -
Nanoparticle-Based Approaches towards the Treatment of Atherosclerosis
by: Artur Y. Prilepskii, et al.
Published: (2020-11-01) -
Mesoporous silica nanoparticles as targeted drug delivery carriers
by: Karol Przemysław Nartowski, et al.
Published: (2022-05-01)